These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7594564)

  • 1. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy.
    Reap EA; Felix NJ; Wolthusen PA; Kotzin BL; Cohen PL; Eisenberg RA
    J Immunol; 1995 Dec; 155(11):5455-62. PubMed ID: 7594564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
    Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
    Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.
    Fukuyama H; Adachi M; Suematsu S; Miwa K; Suda T; Yoshida N; Nagata S
    J Immunol; 1998 Apr; 160(8):3805-11. PubMed ID: 9558084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
    Tamura A; Katsumata M; Greene MI; Yui K
    Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
    Mastache EF; Lindroth K; Fernández C; González-Fernández A
    Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
    Smith KG; Strasser A; Vaux DL
    EMBO J; 1996 Oct; 15(19):5167-76. PubMed ID: 8895561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
    Tamura A; Yui K
    J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological and pathological consequences of mutations in both Fas and Fas ligand.
    Weintraub JP; Godfrey V; Wolthusen PA; Cheek RL; Eisenberg RA; Cohen PL
    Cell Immunol; 1998 May; 186(1):8-17. PubMed ID: 9637760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT; Schmidt MR; Korsmeyer SJ; Gravel KA
    J Immunol; 1996 Mar; 156(6):2143-54. PubMed ID: 8690903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways.
    Kim K; Lee CK; Sayers TJ; Muegge K; Durum SK
    J Immunol; 1998 Jun; 160(12):5735-41. PubMed ID: 9637482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction.
    Garchon HJ; Luan JJ; Eloy L; Bédossa P; Bach JF
    Eur J Immunol; 1994 Feb; 24(2):380-4. PubMed ID: 8299687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell apoptosis causes peripheral T cell depletion in mice transgenic for the HIV-1 vpr gene.
    Yasuda J; Miyao T; Kamata M; Aida Y; Iwakura Y
    Virology; 2001 Jul; 285(2):181-92. PubMed ID: 11437653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
    Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
    J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes.
    Li T; Ramirez K; Palacios R
    Cell Growth Differ; 1996 Jan; 7(1):107-14. PubMed ID: 8788039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
    Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
    J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen.
    Iwakura Y; Itagaki K; Ishitsuka C; Yamasaki Y; Matsuzawa A; Yonehara S; Karasawa S; Ueda S; Saijo S
    J Immunol; 1998 Dec; 161(12):6592-8. PubMed ID: 9862686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crucial role of the thymus in induction by the lprcg gene of lymphadenopathy with autoimmunity in the mouse.
    Matsuzawa A; Moriyama T; Ogata Y; Katagiri T; Kimura M
    Immunology; 1992 Apr; 75(4):688-92. PubMed ID: 1592441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.